Mifepristone in the Treatment of 32 Cases of Uterine Leiomyoma
Chen Pei-ming
Abstract
Chen Pei-ming
Abstract
Objective: To study the long-term effect of mifepristone in the treatment of uterine leiomyoma. Methods: Mifepristone was administered at a daily dosage of 25 mg for 3 months 1n 32 women with uterine leiomyoma. Results: The size of the uterus decreased by 38.10% after 3 months of treatment with mifeprinstone. But the tumour began to grow after the treatment stopped and returned to the size as before. Conclusions: Mifepristone has a short-term effect in the treatment of uterine leiomyoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the long-term effect of mifepristone in the treatment of uterine leiomyoma. Methods: Mifepristone was administered at a daily dosage of 25 mg for 3 months 1n 32 women with uterine leiomyoma. Results: The size of the uterus decreased by 38.10% after 3 months of treatment with mifeprinstone. But the tumour began to grow after the treatment stopped and returned to the size as before. Conclusions: Mifepristone has a short-term effect in the treatment of uterine leiomyoma.
Key concepts: Mifepristone, Leiomyoma, Medicine, Uterine leiomyoma, Uterus, Gynecology, Surgery, Internal medicine